<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC11371517</article-id>
        <article-id pub-id-type="pmcid-ver">PMC11371517.1</article-id>
        <article-id pub-id-type="pmcaid">11371517</article-id>
        <article-id pub-id-type="pmcaiid">11371517</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS2006693</article-id>
        <article-id pub-id-type="pmid">38922339</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-23-3981</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS2006693</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA2006693</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Tumor-agnostic genomic and clinical analysis of <italic toggle="yes">BRAF</italic> fusions identify actionable targets</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chen</surname>
              <given-names initials="MF">Monica F.</given-names>
            </name>
            <xref rid="FN1" ref-type="author-notes">*</xref>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Yang</surname>
              <given-names initials="SR">Soo-Ryum</given-names>
            </name>
            <xref rid="FN1" ref-type="author-notes">*</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Tao</surname>
              <given-names initials="JJ">Jessica J.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Desilets</surname>
              <given-names initials="A">Antoine</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Diamond</surname>
              <given-names initials="EL">Eli L.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wilhelm</surname>
              <given-names initials="C">Clare</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rosen</surname>
              <given-names initials="E">Ezra</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gong</surname>
              <given-names initials="Y">Yixiao</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mullaney</surname>
              <given-names initials="K">Kerry</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Torrisi</surname>
              <given-names initials="J">Jean</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Young</surname>
              <given-names initials="RJ">Robert J.</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Somwar</surname>
              <given-names initials="R">Romel</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Yu</surname>
              <given-names initials="HA">Helena A.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kris</surname>
              <given-names initials="MG">Mark G.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Riely</surname>
              <given-names initials="GJ">Gregory J.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Arcila</surname>
              <given-names initials="ME">Maria E.</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ladanyi</surname>
              <given-names initials="M">Marc</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Donoghue</surname>
              <given-names initials="MTA">Mark T.A.</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rosen</surname>
              <given-names initials="N">Neal</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Yaeger</surname>
              <given-names initials="R">Rona</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Drilon</surname>
              <given-names initials="A">Alexander</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Murciano-Goroff</surname>
              <given-names initials="YR">Yonina R.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="FN1" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Offin</surname>
              <given-names initials="M">Michael</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="FN1" ref-type="author-notes">*</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A2"><label>2</label>Department of Medicine, Weill Cornell Medical College, New York, NY, USA</aff>
        <aff id="A3"><label>3</label>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A4"><label>4</label>Department of Medicine, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA</aff>
        <aff id="A5"><label>5</label>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A6"><label>6</label>Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A7"><label>7</label>Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A8"><label>8</label>Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <author-notes>
          <corresp id="CR1"><bold>Correspondence to:</bold> Dr. Yonina Murciano-Goroff, Address: 1275 York Ave, New York, NY, 10017, <email>muciany@mskcc.org</email>; Dr. Michael Offin, Address: 1275 York Ave, New York, NY, 10017, <email>offinm@mskcc.org</email></corresp>
          <fn fn-type="equal" id="FN1">
            <label>*</label>
            <p id="P1">contributed equally</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>03</day>
          <month>9</month>
          <year>2024</year>
        </pub-date>
        <volume>30</volume>
        <issue>17</issue>
        <issue-id pub-id-type="pmc-issue-id">469988</issue-id>
        <fpage>3812</fpage>
        <lpage>3823</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>28</day>
              <month>07</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>03</day>
              <month>03</month>
              <year>2025</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>03</day>
              <month>03</month>
              <year>2025</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2025-03-04 11:25:34.823">
              <day>04</day>
              <month>03</month>
              <year>2025</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2006693.pdf"/>
        <abstract id="ABS1">
          <sec id="S1">
            <title>Background:</title>
            <p id="P2">Even though <italic toggle="yes">BRAF</italic> fusions are increasingly detected in standard multigene next-generation sequencing panels, few reports have explored their structure and impact on clinical course.</p>
          </sec>
          <sec id="S2">
            <title>Patients and methods:</title>
            <p id="P3">We collected data from patients with <italic toggle="yes">BRAF</italic> fusion-positive cancers identified through a genotyping protocol of 97,024 samples. Fusions were characterized and reviewed for oncogenic potential (in-frame status, non-<italic toggle="yes">BRAF</italic> partner gene, intact <italic toggle="yes">BRAF</italic> kinase domain).</p>
          </sec>
          <sec id="S3">
            <title>Results:</title>
            <p id="P4">We found 241 <italic toggle="yes">BRAF</italic> fusion-positive tumors from 212 patients with 82 unique 5’ fusion partners spanning 52 histologies. 39 fusion partners were not previously reported, and 61 were identified once. <italic toggle="yes">BRAF</italic> fusion incidence was enriched in pilocytic astrocytomas, gangliomas, low-grade neuroepithelial tumors, and acinar cell carcinoma of the pancreas. 24 patients spanning multiple histologies were treated with MAPK-directed therapies of which 20 were evaluable for RECIST. Best response was partial response (<italic toggle="yes">N</italic>=2), stable disease (<italic toggle="yes">N</italic>=11), and progressive disease (<italic toggle="yes">N</italic>=7). The median time on therapy was 1 month with MEK plus BRAF inhibitors ([<italic toggle="yes">N</italic>=11], range 0-18 months) and 8 months for MEK inhibitors ([<italic toggle="yes">N</italic>=14], range 1-26 months). 9 patients remained on treatment for longer than 6 months [pilocytic astrocytomas (<italic toggle="yes">N</italic>=6), Erdheim-Chester disease (<italic toggle="yes">N</italic>=1), extraventricular neurocytoma (<italic toggle="yes">N</italic>=1), melanoma (<italic toggle="yes">N</italic>=1)]. Fifteen patients had acquired <italic toggle="yes">BRAF</italic> fusions.</p>
          </sec>
          <sec id="S4">
            <title>Conclusions:</title>
            <p id="P5"><italic toggle="yes">BRAF</italic> fusions are found across histologies and represent an emerging actionable target. <italic toggle="yes">BRAF</italic> fusions have a diverse set of fusion partners. Durable responses to MAPK therapies were seen, particularly in pilocytic astrocytomas. Acquired <italic toggle="yes">BRAF</italic> fusions were identified after targeted therapy underscoring the importance of post-progression biopsies to optimize treatment at relapse in these patients.</p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd><italic toggle="yes">BRAF</italic> fusion</kwd>
          <kwd>pilocytic astrocytoma</kwd>
          <kwd>MAPK targeted therapy</kwd>
          <kwd>acquired resistance</kwd>
          <kwd>EGFR targeted therapy</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
